Literature DB >> 20159048

First isolation of Desulfovibrio from the human vaginal flora.

Suguru Ichiishi1, Kaori Tanaka, Kenichi Nakao, Koji Izumi, Hiroshige Mikamo, Kunitomo Watanabe.   

Abstract

Four Desulfovibrio species, including 2 subtypes of 1 species, namely, Desulfovibrio piger, Desulfovibrio desulfuricans MB subtype and Essex 6 subtype, Desulfovibrio fairfieldensis, and Desulfovibrio vulgaris, have been isolated from the human oral and intestinal flora, but not previously from the vaginal flora. They are opportunistic pathogens and have been considered as possible environmental and etiologic agents involved in ulcerative colitis and chronic periodontitis. We isolated Desulfovibrio intestinalis from vaginal specimens of four Japanese women; a species which has not been previously isolated from humans. The vaginal isolates were highly resistant to cefoxitin, piperacillin, and piperacillin-tazobactam but were susceptible to the other antimicrobial agents tested. Our findings suggested that vaginal Desulfovibrio species may be involved in gynecological or obstetric pathology, and provides additional information of the medical relevance on human Desulfovibrio species. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159048     DOI: 10.1016/j.anaerobe.2010.02.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  8 in total

1.  Genome sequence of Desulfovibrio sp. A2, a highly copper resistant, sulfate-reducing bacterium isolated from effluents of a zinc smelter at the Urals.

Authors:  Stefano Mancini; Helge K Abicht; Olga V Karnachuk; Marc Solioz
Journal:  J Bacteriol       Date:  2011-12       Impact factor: 3.490

2.  Desulfovibrio legallii prosthetic shoulder joint infection and review of antimicrobial susceptibility and clinical characteristics of Desulfovibrio infections.

Authors:  Shawn Vasoo; Erin L Mason; Daniel R Gustafson; Scott A Cunningham; Nicolynn C Cole; Emily A Vetter; Scott P Steinmann; Walter R Wilson; Robin Patel; Elie F Berbari; Nancy K Henry
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

3.  Lactobacillus salivarius REN counteracted unfavorable 4-nitroquinoline-1-oxide-induced changes in colonic microflora of rats.

Authors:  Ming Zhang; Xuewei Qiao; Liang Zhao; Lu Jiang; Fazheng Ren
Journal:  J Microbiol       Date:  2011-12-28       Impact factor: 3.422

4.  Hybrid cluster proteins and flavodiiron proteins afford protection to Desulfovibrio vulgaris upon macrophage infection.

Authors:  Mafalda C O Figueiredo; Susana A L Lobo; Sara H Sousa; Fábio P Pereira; Judy D Wall; Lígia S Nobre; Lígia M Saraiva
Journal:  J Bacteriol       Date:  2013-04-05       Impact factor: 3.490

5.  An HcpR paralog of Desulfovibrio gigas provides protection against nitrosative stress.

Authors:  Sofia M da Silva; Catarina Amaral; Susana S Neves; Cátia Santos; Catarina Pimentel; Claudina Rodrigues-Pousada
Journal:  FEBS Open Bio       Date:  2015-07-09       Impact factor: 2.693

6.  Insights into the Evolution of Host Association through the Isolation and Characterization of a Novel Human Periodontal Pathobiont, Desulfobulbus oralis.

Authors:  Karissa L Cross; Payal Chirania; Weili Xiong; Clifford J Beall; James G Elkins; Richard J Giannone; Ann L Griffen; Adam M Guss; Robert L Hettich; Snehal S Joshi; Elaine M Mokrzan; Roman K Martin; Igor B Zhulin; Eugene J Leys; Mircea Podar
Journal:  mBio       Date:  2018-03-13       Impact factor: 7.867

7.  First case of Desulfovibrio desulfuricans bacteraemia successfully identified using MALDI-TOF MS.

Authors:  R Nasreddine; M A Argudin; M Herpol; V Y Miendje Deyi; N Dauby
Journal:  New Microbes New Infect       Date:  2019-10-23

8.  Changes in the Intestine Microbial, Digestive, and Immune-Related Genes of Litopenaeus vannamei in Response to Dietary Probiotic Clostridium butyricum Supplementation.

Authors:  Yafei Duan; Yun Wang; Hongbiao Dong; Xian Ding; Qingsong Liu; Hua Li; Jiasong Zhang; Dalin Xiong
Journal:  Front Microbiol       Date:  2018-09-19       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.